Trial Search Results

Treating Tobacco Dependence in Inpatient Psychiatry - 1

The purpose of this study is to test in a randomized clinical trial a series of hypotheses concerning the efficacy of an extended expert-system intervention plus nicotine replacement therapy (NRT) for treating tobacco dependence among patients hospitalized on a smoke-free psychiatric unit.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institute on Drug Abuse (NIDA)

Stanford Investigator(s):


  • Behavioral: stage-tailored intervention


Phase 2


Inclusion Criteria: Men and women over 18 years of age hospitalized on an inpatient
psychiatric unit who report smoking at least 5 cigarettes per day; smoking at least 100
cigarettes in one's lifetime, residing in the San Francisco Bay Area with no plan to
relocate outside of the area in the next 18 months, and access to a telephone for
scheduling follow up assessments.

Exclusion Criteria: Dementia or other brain injury precluding ability to participate;
non-English speaking; severe agitation, psychosis, or hostility; and medical
contraindications to nicotine replacement therapy (NRT). Recruitment of acutely psychotic,
manic, or hostile patients will be delayed until there is significant reduction of these
symptoms. Medical contraindications are: myocardial infarction in the preceding 3 months,
unstable angina pectoris, liver or kidney disease, current pregnancy or breast feeding,
allergies to adhesives, or other medical conditions that the medical team deems
incompatible with NRT use.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting